BioCardia, Inc. Proceeds from Sale of Productive Assets
BioCardia, Inc. (BCDA) reported Proceeds from Sale of Productive Assets of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2013-03-22
- BioCardia, Inc. proceeds from sale of productive assets for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. proceeds from sale of productive assets for the quarter ending 2012-09-30 was $0.00.
- BioCardia, Inc. proceeds from sale of productive assets for the quarter ending 2011-12-31 was $560.00K.
- BioCardia, Inc. proceeds from sale of productive assets for the quarter ending 2011-09-30 was -$411.00K.
- BioCardia, Inc. proceeds from sale of productive assets for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- BioCardia, Inc. proceeds from sale of productive assets for fiscal 2011 was $17.18M.
- BioCardia, Inc. proceeds from sale of productive assets for fiscal 2010 was $0.00.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 6 month as first filed | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 10-K · filed 2013-03-22 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-10 | ||||
| 2011-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $149.00K derived: sum of 2 quarters · filed 2013-03-22 | $17.18M 10-K · filed 2013-03-22 | ||
| 2011-09-30 | -$411.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $16.61M 10-Q · filed 2012-11-08 | |||
| 2011-06-30 | $17.03M 10-Q · filed 2012-08-10 | $17.59M 10-Q · filed 2011-08-11 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $0.00 derived: sum of 2 quarters · filed 2012-03-29 | $0.00 10-K · filed 2012-03-29 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-15 | $0.00 10-Q · filed 2011-11-15 | |||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |